Article
Functional Precision Oncology: The Next Frontier to Improve Glioblastoma Outcome?
International journal of molecular sciences - 3 Aug 2022
Panovska Dena, De Smet Frederik
Abstract excerpt
Glioblastoma remains the most malignant and intrinsically resistant brain tumour in adults. Despite intensive research over the past few decades, through which numerous potentially druggable targets have been identified, virtually all clinical trials of the past 20 years have failed to improve the outcome for the vast majority of GBM patients. The observation that small subgroups of patients displayed a...
Topics
- Adult
- Brain Neoplasms
- Glioblastoma
- Humans
- Medical Oncology
- Mutation
- Precision Medicine